Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Antipsychotic (1)
- Anxiety (1)
- Biopsychosocial (1)
- CAPS-5 (1)
- Case report (1)
-
- Clinical management (1)
- FMRI (1)
- Functional Magnetic Resonance Imaging (1)
- Integrated Behavioral Health (1)
- Integrative Medicine (1)
- Medical Informatics Applications (1)
- Mental health (1)
- Mental illness (1)
- Olanzapine (1)
- PTSD (1)
- Patient Handoff (1)
- Primary Care (1)
- Psychiatry (1)
- Psychosocial (1)
- Schizophrenia (1)
- Warm Handoff (1)
Articles 1 - 3 of 3
Full-Text Articles in Mental Disorders
Biopsychosocial Case Report, David F. Lo, Gaurav Kumar, Don D. Shamilov
Biopsychosocial Case Report, David F. Lo, Gaurav Kumar, Don D. Shamilov
Rowan-Virtua Research Day
Ms. R, a 32-year-old Hispanic female, suffers from severe anxiety exacerbated by a car accident and past struggles with depression and substance use. Evaluation reveals hypothyroidism, mild anemia, and GAD as the primary diagnosis. Factors contributing to her condition include genetic predispositions, medical issues, and social stressors. Treatment involves pharmacotherapy, psychotherapy, and monitoring her physiological health. Research on wearable data for GAD severity offers potential insights for her treatment. A holistic approach, considering biological, psychological, and social factors, guides her tailored treatment plan for overall well-being.
Investigation Of The Utility Of A Ptsd Coaching Mobile App To Address Mental Health Services Demand In A Primary Care Clinic: Analysis Of Caps-5 Measures, Sindhura Nemani, Danielle Rae Schweitzer, Anne C. Jones
Investigation Of The Utility Of A Ptsd Coaching Mobile App To Address Mental Health Services Demand In A Primary Care Clinic: Analysis Of Caps-5 Measures, Sindhura Nemani, Danielle Rae Schweitzer, Anne C. Jones
Rowan-Virtua Research Day
The COVID-19 pandemic affected countless people globally, resulting in a greater need for mental health professionals and resources1. The demand for mental health care is soaring yet the limitation of resources has strained the healthcare system, making it challenging to help patients in a timely manner2. This poster represents a snapshot of a larger project that is striving to investigate an intervention to help bridge the gap between patient need and prompt referral through a warm handoff approach and use of the PTSD Coach mobile application as well as exploring patients’ satisfaction3,4,5,6,8,9. In this …
Using Fmri To Assess Effectiveness Of Olanzapine Treatment For Schizophrenia, William Kyle Copenhaver, David F. Lo, Hanna Rothenberg, Eeshan Khurana, Valerie Rome, Uzayr Wasif, Don D. Shamilov
Using Fmri To Assess Effectiveness Of Olanzapine Treatment For Schizophrenia, William Kyle Copenhaver, David F. Lo, Hanna Rothenberg, Eeshan Khurana, Valerie Rome, Uzayr Wasif, Don D. Shamilov
Rowan-Virtua Research Day
Schizophrenia is a complex mental illness with neurobiological underpinnings and misconceptions about violence. Schizophrenia is associated with high levels of creativity and structural traits like fewer D2 receptors. Patients face reduced life expectancy due to cardiovascular diseases and cope through smoking and sedentariness. Treatment involves pharmacological antipsychotics like olanzapine and nonpharmacological approaches. Olanzapine works by antagonizing D2 receptors but has side effects like weight gain and diabetes risk. fMRI is used to study treatment mechanisms and predict response, but research on olanzapine's brain network effects is limited.